Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.65 CAD | +4.29% | +6.73% | +25.86% |
05-17 | XORTX Therapeutics Reprices Warrants Connected With U.S. IPO | MT |
05-17 | XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.86% | 7.78M | |
+16.26% | 121B | |
+13.40% | 107B | |
-5.64% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.48% | 15.31B | |
+3.14% | 14.08B | |
+24.22% | 11.74B |
- Stock Market
- Equities
- XRTX Stock
- News XORTX Therapeutics Inc.
- XORTX Therapeutics Names James Fairbairn Interim Chief Financial Officer